News
AVTX
14.20
+9.23%
1.20
Weekly Report: what happened at AVTX last week (0415-0419)?
Weekly Report · 2d ago
Avalo Therapeutics (AVTX) Price Target Increased by 4566.67% to 35.70
NASDAQ · 04/17 01:38
Oppenheimer Upgrades Avalo Therapeutics (AVTX)
NASDAQ · 04/17 01:38
Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
Oppenheimer upgraded Avalo Therapeutics Inc (NASDAQ:AVTX) to Outperform. The analyst says AVTX-009 is a promising drug candidate and looks forward to a Phase 2 topline data in 2026 in hidradenitis suppurativa. In March, Avalo announced the acquisition of an anti-IL-1β drug candidate.
Benzinga · 04/16 18:25
Avalo Therapeutics Price Target Announced at $35.00/Share by Oppenheimer
Dow Jones · 04/16 13:03
Avalo Therapeutics Raised to Outperform From Perform by Oppenheimer
Dow Jones · 04/16 13:03
AVALO THERAPEUTICS <AVTX.O>: OPPENHEIMER RAISES TO OUTPERFORM FROM PERFORM
Reuters · 04/16 12:53
Oppenheimer Upgrades Avalo Therapeutics to Outperform, Announces $35 Price Target
Benzinga · 04/16 12:52
U.S. RESEARCH ROUNDUP-Advanced Micro Devices, Kroger, Tyson Foods
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Advanced Micro Devices, Kroger and Tyson Foods among companies with new targets. Analysts raise ratings and target prices on several companies. Boeing, Caterpillar and AIG among those with targets raised.
Reuters · 04/16 07:18
Weekly Report: what happened at AVTX last week (0408-0412)?
Weekly Report · 04/15 09:30
12 Health Care Stocks Moving In Tuesday's After-Market Session
Jaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday's after-market session. The company's market cap stands at $31.1 million. ATyr Pharma shares rose 10.45% and Corvus Pharma shares increased by 7.36%. Apyx Medical shares declined by 6.1% during the session.
Benzinga · 04/09 20:31
Weekly Report: what happened at AVTX last week (0401-0405)?
Weekly Report · 04/08 09:32
SOL, MESO and ACOR among pre-market losers
SOL, MESO and ACOR among pre-market losers. View reaches deal with Cantor Fitzgerald and RXR to become a private company. BCAN, HWH, ANGH, PTPI, MDAI, VIEW, and VIEW are also losers.
Seeking Alpha · 04/03 12:12
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Stryve Foods, Inc. (NASDAQ:SNAX) fell sharply following a fourth-quarter revenue miss. The company posted adjusted loss of $1.90 per share. VivoPower International PLC shares surged 315% to $6.10 after the company announced a merger.
Benzinga · 04/02 17:23
Avalo Therapeutics (AVTX) Surges 270% in a Week: Here's Why
NASDAQ · 04/02 15:30
HUT, CXAI and BDRX among pre-market losers
HUT, CXAI and BDRX among pre-market losers. Acorda Therapeutics files for Chapter 11 bankruptcy. Canoo reports mixed Q4 results. Humana, Hut 8 Corp, and iBio among other companies downgraded. Bitcoin production slips.
Seeking Alpha · 04/02 12:37
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
MSP Recovery (NASDAQ:LIFW) stock increased by 61.9% to $1.08 during Tuesday's pre-market session. Serina Therapeutics (AMEX:SER) stock moved upwards by 28.33%. CareMax (NASdaq:CMAX) and Imunon stock rose by 18.49% and 16.58% respectively. Losers Acorda Therapeutic and Gritstone Bio lost 75.1% of their value.
Benzinga · 04/02 12:07
Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Shares of VirTra, Inc. Rose sharply in today's pre-market trading after the company reported better-than-expected fourth-quarter results. VirTra shares jumped 20% to $11.45 in pre- market trading. The company's sales came in at $10.100 million.
Benzinga · 04/02 12:04
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
XTI Aerospace (NASDAQ:XTIA) stock is rocketing more than 94% alongside heavy pre-market trading. Merger agreements, earnings reports, and a major spinoff are worth watching on Tuesday morning. The biggest pre- market stock movers include XTI Aerospace, Kidpik and MSP Recovery.
Investorplace · 04/02 11:38
AVALO THERAPEUTICS APPOINTS BIOTECH LEADERS TO BOARD OF DIRECTORS
Reuters · 04/02 11:00
More
Webull provides a variety of real-time AVTX stock news. You can receive the latest news about Avalo Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About AVTX
Avalo Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The Company's lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases. Its pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein). AVTX-009 is a humanized monoclonal antibody (IgG4) that binds to interleukin-1β (IL-1β) with high affinity and neutralizes its activity. IL- 1β is a central driver in the inflammatory process. Quisovalimab is a fully human monoclonal antibody (mAb), directed against human LIGHT (Lymphotoxin-like, exhibits Inducible expression, and competes with Herpes Virus Glycoprotein D for Herpesvirus Entry Mediator (HVEM), a receptor expressed by T lymphocytes). AVTX-008 is a fully human B and T Lymphocyte Attenuator (BTLA) agonist fusion protein. AVTX-008 is differentiated by having specific binding to BTLA, with no binding to LIGHT or CD160.